ArticleiScience2025

Design of a fragment crystallizable-engineered tetravalent bispecific antibody targeting programmed cell death-1 and vascular endothelial growth factor with cooperative biological effects.

Tingting Zhong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.